Min Lan Selected Research

Beclin-1

10/2019

Valosin-containing protein promotes metastasis of osteosarcoma through autophagy induction and anoikis inhibition via the ERK/NF-κβ/beclin-1 signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Lan Research Topics

Disease

4	Neoplasms (Cancer) 12/2022 - 10/2017
4	Neoplasm Metastasis (Metastasis) 10/2019 - 01/2017
3	Wounds and Injuries (Trauma) 08/2022 - 12/2020
3	Infections 01/2021 - 11/2020
2	Myopia 02/2022 - 02/2022
2	Inflammation (Inflammations) 01/2022 - 09/2021
2	Spinal Cord Injuries (Spinal Cord Injury) 09/2021 - 10/2017
2	Bacterial Infections (Bacterial Infection) 01/2021 - 12/2020
2	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 10/2019
1	Chondrosarcoma 01/2023
1	Melanoma (Melanoma, Malignant) 12/2022
1	COVID-19 01/2022
1	Hypoalbuminemia 08/2021
1	Anemia 08/2021
1	Osteoporosis 01/2020
1	Ocular Hypertension (Glaucoma, Suspect) 10/2019
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 10/2019
1	Ileus 09/2019
1	Fibrosis (Cirrhosis) 08/2019
1	Diarrhea 04/2019
1	Lung Neoplasms (Lung Cancer) 10/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2017
1	Hypoxia (Hypoxemia) 10/2017
1	Neurologic Manifestations (Neurological Manifestations) 10/2017
1	Spinal Injuries (Spinal Injury) 10/2017
1	Multiple Fractures 10/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2018
2	Small Interfering RNA (siRNA)IBA 01/2022 - 08/2019
2	Circular RNAIBA 09/2021 - 01/2020
2	Peptides (Polypeptides)IBA 01/2021 - 12/2020
2	CalciumIBA 11/2017 - 01/2017
1	A 7 (A-7)IBA 01/2023
1	N 30IBA 01/2023
1	Messenger RNA (mRNA)IBA 12/2022
1	Long Noncoding RNAIBA 12/2022
1	AmarisIBA 02/2022
1	SuspensionsIBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	PotassiumIBA 08/2021
1	Photosensitizing Agents (Photosensitizers)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	GoldIBA 01/2021
1	GelatinIBA 12/2020
1	HydrogelsIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	CollagenIBA 12/2020
1	VaccinesIBA 11/2020
1	hydroquinone (Esoterica)FDA Link 11/2020
1	arctigeninIBA 01/2020
1	GATIBA 10/2019
1	Valosin Containing ProteinIBA 10/2019
1	Beclin-1IBA 10/2019
1	CytokinesIBA 08/2019
1	Antiviral Agents (Antivirals)IBA 04/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	MicellesIBA 01/2018
1	Epirubicin (Ellence)FDA LinkGeneric 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Hemoglobins (Hemoglobin)IBA 11/2017
1	Phosphotransferases (Kinase)IBA 10/2017
1	3' Untranslated Regions (3' UTR)IBA 10/2017
1	ErbB Receptors (EGF Receptor)IBA 10/2017
1	Fibrinogen (Factor I)FDA Link 10/2017
1	Alkaline PhosphataseIBA 01/2017
1	hemoglobin ASIBA 01/2017

Therapy/Procedure

3	Lasers (Laser) 02/2022 - 12/2020
2	Laser In Situ Keratomileusis (LASIK) 02/2022 - 02/2022
1	Length of Stay 08/2022
1	Excimer Lasers 02/2022
1	Therapeutics 01/2021
1	Photochemotherapy (Photodynamic Therapy) 12/2020
1	Spinal Fusion (Spondylosyndesis) 09/2019